EIF2AK4 and fatty liver disease: For example, GCN2 deficiency significantly attenuated HFD-induced liver dysfunction, hepatic steatosis, and IR via regulation of lipogenic genes (SREBP-1/PPARγ) and their downstream targets (FASN, CD36, SCD1) [141].